NexImmune Establishes Research Initiative with City of Hope to Focus on Novel Immunotherapeutic Approaches to Acute Myeloid Leukemia

    NEXT STORY
    RespireRx Pharmaceuticals Inc. Announces Appointment of Dr. James Cook and Dr. Jeffrey Witkin as Research Fellows
    PREV STORY
    Immune Health Supplements Market Worth USD 29.40 Billion at 7.4% CAGR; Rapid Changes in Lifestyles to Bolster Growth, says Fortune Business Insights™
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Oncobiologics Advances ONS-5010 into wet AMD Clinical Trial

    Receives commitment for $20 million in proceeds from equity private placement Restructures and extends ...

    author_avatar
    NASDAQ Market News

    EyePoint Pharmaceuticals Presents Data Showcasing DEXYCU® at the American Society of Cataract and Refractive Surgery 2020 Virtual Annual Meeting

    author_avatar
    NASDAQ Market News

    Cytokinetics Announces Additional COSMIC-HF Results to Be Presented at Heart Failure 2016

    SOUTH SAN FRANCISCO, Calif., May 13, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, (Nasdaq:CYTK) announced today ...

    author_avatar
    NASDAQ Market News